AllQuantitative Report
logoArgusMarch 31, 2021

VNDA: Rating increased to a BUY

Symbols
VNDA
Sector(s)
Healthcare
Rating
Current Price
$17.76
Price Target
$NaN
Earnings Estimate
Summary

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients.

Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Try it Free